SAVA Q2 2019 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$308

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$591,000

Free Cash Flow

-$591,000

Stock-Based Comp.

$329,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$982,000

Stockholders' Equity

$18M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$308	-$1,463	+78.9%
Operating Income	-$1M	-$2M	+53.1%
Net Income	-$1M	-$2M	+56.8%